---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-301187"
form_type: "8-K"
ticker: "GH"
cik: "0001576280"
company_name: "Guardant Health, Inc."
filed_at: "2023-12-21T23:59:59+00:00"
generated_at: "2026-06-07T09:04:08.748416+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Guardant Health raises $90.7M in registered direct offering with Baillie Gifford

## Summary
- Raised ~$90.7M gross via 3,387,446 shares sold at $26.77 each to Baillie Gifford-managed accounts.
- Net proceeds ~$90.6M; funds earmarked for general corporate purposes including working capital and capex.
- Offering closed Dec 21, 2023; executed under effective shelf registration statement on Form S-3.
- CEO Helmy Eltoukhy noted strong support from Baillie Gifford as Guardant expands precision oncology portfolio.

## SEC filing metadata
- accession: 0001193125-23-301187
- form_type: 8-K
- ticker: GH
- cik: 0001576280
- company_name: Guardant Health, Inc.
- filed_at: 2023-12-21T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1576280/000119312523301187/0001193125-23-301187-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1576280/000119312523301187/d518375d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-301187
- JSON: https://secwatch.observer/filing/0001193125-23-301187.json
- Plain text: https://secwatch.observer/filing/0001193125-23-301187.txt

## Key facts
- Material Agreements
  Guardant Health, Inc. entered into Common Stock Purchase Agreement with certain institutional investors valued at 3,387,446 shares at $26.77 per share, gross proceeds ~$90.7 million (effective 2023-12-20).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional investors
  - Value: 3,387,446 shares at $26.77 per share, gross proceeds ~$90.7 million
  - Effective: 2023-12-20
  source text: On December 20, 2023, Guardant Health, Inc. (the “Company”) entered into a common stock purchase agreement (the “Purchase Agreement”) for the issuance and sale in a registered direct offering of 3,387,446 shares of the Company’s common stock, par value $0.00001 per share (the “Shares”), to certain institutional investors at an offering price of $26.77 per share, for gross proceeds of approximately $90.7 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1576280/000119312523301187/0001193125-23-301187-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.